Form D · Biotechnology
CHITOGEN INC
Plymouth, MN · CIK 0001470264
Offering snapshot reported Dec 13, 2023 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1.05M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $35K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 13, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 16, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 6, 2022 | Amendment | $523,500 | $316,500vs Oct 9, 2018 | 13 | SEC filing |
| Oct 9, 2018 | Initial | $207,000 | No comparison | 7 | SEC filing |
| May 29, 2015 | Initial | $35,000 | No comparison | 1 | SEC filing |
| Jul 2, 2014 | Amendment | $1,548,150 | $1,443,150vs Nov 13, 2013 | 23 | SEC filing |
| Nov 13, 2013 | Initial | $105,000 | No comparison | 2 | SEC filing |
| Jan 21, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-499547
Source: Form D, filed Dec 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frederick Albright | Director |
| James Drake | Director |
| Douglas Eayrs | Director, Executive |
| Albert Emola | Director, Executive |
| Kai Kroll | Director, Executive |
| Robert Levy | Director |
| Steve Muellerleile | Executive |
| Michael Patrick Reilly | Director, Executive |
| Thomas Ritter | Executive |
| Donald Sturtevant | Director |
| Yong Zhu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12805 Hwy 55 Suite 202
Plymouth, MN, 55441-3880
Plymouth, MN, 55441-3880